07:10 AM EDT, 05/01/2024 (MT Newswires) -- IDEXX Laboratories ( IDXX ) reported Q1 earnings Wednesday of $2.81 per diluted share, up from $2.55 a year earlier.

Analysts polled by Capital IQ expected $2.67.

Revenue for the quarter ended March 31 was $964.1 million compared with $900.2 million a year earlier.

Analysts polled by Capital IQ expected $965.8 million.

The company lowered its full-year EPS outlook to between $10.82 and $11.20 from the previous range of $10.84 to $11.33, and $3.90 billion to $3.97 billion in revenue, from $3.93 billion to $4.04 billion previously. Analysts polled by Capital IQ expect $11.12 in EPS on revenue of $3.99 billion.

IDEXX ( IDXX ) shares were off 1% in premarket trading.

Price: 488.00, Change: -4.76, Percent Change: -0.97